The penultimate step in the biosynthesis of the human ABO blood group oligosaccharide antigens is catalyzed by a-(1,2)-fucosyltransferase(s) (GDP-L-fucose:flDgalactoside 2-a-L-fucosyltransferase, EC 2.4.1.69), whose expression is determined by the H and Secretor (SE) blood group loci (also known as FUTI and FUT2, respectively). These enzymes construct Fucal -) 2Galh3-linkages, known as H determinants, which are essential precursors to the A and B antigens. Erythrocytes from individuals with the rare Bombay and para-Bombay blood group phenotypes are deficient in H determinants, and thus A and B determinants, as a consequence of apparent homozygosity for null alleles at the H locus.
and para-Bombay blood group phenotypes are deficient in H determinants, and thus A and B determinants, as a consequence of apparent homozygosity for null alleles at the H locus.
We report a molecular analysis of a human a-(1,2)-fucosyltransferase gene, thought to correspond to the H blood group locus, in a Bombay pedigree and a para-Bombay pedigree. We find inactivating point mutations in the coding regions of both alleles of this gene in each H-deficient individual. These results define the molecular basis for H blood group antigen deficiency in Bombay and para-Bombay phenotypes, provide compelling evidence that this gene represents the human H blood group locus, and strongly support a hypothesis that the H and SE loci represent distinct a-(1,2)-fucosyltransferase genes. Candidate sequences for the human SE locus are identified by low-stringency Southern blot hybridization analyses, using a probe derived from the H a-(1,2)-fucosyltransferase gene.
The antigens determined by the human ABO blood group locus are oligosaccharide molecules constructed by the sequential action of specific glycosyltransferases. The final step in this pathway is catalyzed by allelic glycosyltransferases encoded by the ABO locus. These enzymes require a precursor oligosaccharide substrate (Fucal -* 2Galf-) known as the H blood group antigen, constructed by a-(1,2)-fucosyltransferase(s) [a(1,2)FTs; GDP-L-fucose:43D-galactoside 2-a-L-fucosyltransferase, EC 2.4.1.69]. Genetic and biochemical observations are consistent with a hypothesis that the H and Secretor (SE) blood group loci (also known as FUTI and FUT2, respectively) correspond to distinct a(1,2)FT genes with tissue-specific expression patterns and close genetic linkage on chromosome 19 (1) (2) (3) (4) (5) (6) . Under this two-locus model (2) , the human H blood group locus determines expression of the H antigen (as well as A and/or B antigens) in the erythroid lineage, whereas the SE locus controls H expression (and thus A or B antigen expression) in a variety of secretory epithelia and in saliva (Table 1) .
Nearly all humans maintain at least one functional H allele (1) . Roughly 80% of these (Secretors) also maintain at least one functional SE allele, whereas the remainder (non- (1) . These persons are believed to be homozygous for null alleles at the H locus (1, 2) but apparently have at least one functional SE allele. The basis for null alleles at these loci has not been defined, nor has the two-locus hypothesis been confirmed at the molecular level. We have previously isolated a human a(1,2)FT cDNA whose cognate enzyme is kinetically similar to that of the H a(1,2)FT and whose chromosomal location (number 19) is syntenic to the H blood group locus (9) . To confirm the hypothesis that this cDNA corresponds to the H locus, and to identify the molecular basis for deficiency of H determinants in presumed h/h individuals, we determined the genomic structure and sequence of a wild-type allele and compared it to alleles taken from H-deficient individuals. Inactivating point mutations were identified within the coding portions of each such allele, including alleles in individuals with wild-type SE locus-determined H antigen expression. These results yield a molecular explanation for ABH blood group deficiency in Bombay and para-Bombay individuals, provide genetic support for assignment of this a(l,2)FT gene to the H locus, and indicate that the SE locus represents an a(1,2)FT gene distinct from the H locus.
MATERIALS AND METHODS
Cloning of a(1,2)FT Alleles. Genomic DNA sequences corresponding to a previously described human a(1,2)FT cDNA [pCDM7-a(1,2)FT; ref. 9] were isolated from phage genomic DNA libraries prepared from leukocyte DNA isolated from an H-positive individual and from an H-deficient Abbreviation: a(1,2)FT, a-(1,2)-fucosyltransferase.
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individual (X; Bombay phenotype) (10) . Libraries were screened by plaque hybridization (11) using a 1.2-kb Hinfl fragment isolated from the insert in pCDM7-a(1,2)FT (9) . Adjacent EcoRI fragments of 2.7 and 6.5 kb from a single phage were subcloned into the unique EcoRI site in the vector pWE15 (Stratagene). Both strands of these fragments were sequenced by using oligonucleotide primers corresponding to the insert sequence.
The coding sequences of the two alleles (Y1 and Y2) from a para-Bombay individual were generated with the PCR (11), using primer pairs flanking the mutation in Y2 (Fig. 1) Expression Vector Construction and Analysis. Expression vectors containing single or multiple mutations were assembled with restriction fragment exchange procedures (11), using restriction sites in the 6.5-kb EcoRI fragment that encompasses the two a(1,2)FT exons ( Fig. 1) , cloned into the EcoRI site of vector pWE15 (12) . Details of vector constructions are available from the authors. COS-1 cells were transfected by a DEAE-dextran procedure (11) . A control vector (pCDM7-CAT) encoding chloramphenicol acetyltransferase [derived from pSV2-CAT (11) and pCDM7 (9)] was cotransfected to allow normalization for transfection efficiency. Cell extracts were prepared 72 hr after transfection (9) and were used in a(1,2)FT activity assays (12) of the human a(1,2)FT cDNA (9) . Primer-extension analyses (data not shown) define the gene's transcription initiation site (boldface C) in a cell line (A431) that expresses this gene (9, 12) . Region indicated by B corresponds to the 5' splice junction between exon I and the intron (... AGCAGCTCGGgtaagtgg ... .; intronic sequence in lowercase letters). ut, Untranslated region. Region indicated by C in the schematic corresponds to the 3' splice junction between the intron (lowercase letters) and exon 2 (uppercase letters) (. . .caglgcatttgctaattcgcctttcctcccctgcagCC ATG TGG CTC ... .). Underlined t residue in this sequence corresponds to mutation X3 (see b). Underlined ATG residues correspond to the enzyme's initiator methionine codon (9) . Restriction sites used to create chimeric a(1,2)FT vectors (see Fig. 2 ), and the EcoRI and Dra I sites used in Fig. 5 Extracts were also subjected to chloramphenicol acetyltransferase activity assays (11) .
Pedigree Analyses. H and Lewis blood group phenotypes of each individual were determined by standard blood typing procedures (13) . For PCR analyses, genomic DNA was prepared from peripheral blood (11) , or from freshly plucked hairs (14) , and was used as PCR template under the reaction conditions described above. PCR primers used to sample the X4 and Y2 positions (GCGCAAGCTTGCGCCGTGGGGAC-TATCTGCAGGTTATGCC and GCGCTCTAGAQTfJ-Q CATTAATGCCCACCCACTCGGGCAG) correspond to positions 657-686 and 1035-1065, respectively, of the a1,2)FT cDNA (9) . Thirty nucleotides of each primer (underlined) are derived from the cDNA sequence. Ten flanking nucleotides include a restriction site (LindI, AAGCTT; Xba I, TCTAGA). The Y1 position was analyzed using nested PCR primers. The outermost pair corresponds to positions 335-364 (TCCTGCCTGCCATGCATGCCGCCCTGGCCC) and 657-686 (GGCATAACCTGCAGATAGTCCCCACG-GCGC) of the a(1,2)FT cDNA (9) . The inner pair corresponds to positions 366-395 (GGTATTCCGCATCACCCT-GCCCGTGCTGGC) and 626-655 (CGTGGACGCCGA-CAAAGGTGCGCGGGCGGT).
PCR products were then subjected to restriction endonuclease digestion and acrylamide gel electrophoresis (see Figs.  3 and 4) . Products encompassing the Y1 position were also fixed to nylon hybridization membranes and probed with 32P-labeled (11) allele-specific oligonucleotides (15) (wildtype probe, CTGAAGCTCTCTGGC; Y1-specific probe, CT-GAAGCACTCTGGC) (see Fig. 4 ). Filters were hybridized at 370C in 5x standard saline phosphate/EDTA (SSPE)/5x Denhardt's solution/0.5% SDS/0.1 mg of sheared salmon sperm DNA per ml, rinsed in 2x SSPE/0.1% SDS at room temperature, washed for 10 min at 420C in 2x SSPE/0.1% SDS, and subjected to autoradiography. RESULTS To identify DNA sequence differences that might inactivate the a(1,2)FT gene in Bombay individuals, we sequenced =6.5 kb of genomic DNA encompassing a wild-type allele and the corresponding 6.5-kb region in a Bombay allele (Fig. 1) . The Bombay allele (individual X in Fig. 1 ) differs from the wild-type allele at six positions. Three of these single nucleotide differences are in the gene's single intervening sequence (X1, X2, X3), one is within the coding region (X4), and two are in the 3' untranslated region (X5, X6). The sequence difference in the coding region (X4) is a nonsense mutation that creates a termination codon corresponding to amino acid 316 of the wild-type a(1,2)FT (Tyr-316 --ter). This sequence alteration predicts a mutant polypeptide that is missing the 50 C-terminal amino acids of the wild-type enzyme.
A Nonsense Mutation Inactivates the a(1,2)FT Gene in a Bombay Individual. To confirm that the Tyr-316 -* ter mutation inactivates this allele, this DNA sequence difference and each of the others were moved into the wild-type sequence background and tested for function by transfection into an a(1,2)FT-deficient mammalian host (COS-1 cells; ref.
9) (Fig. 2) . The wild-type construct (plasmid pHHH; Fig. 2 (Fig. 1) . Allele assignment at this position was therefore accomplished by restriction analysis of the corresponding segment of the coding region generated by the PCR (Fig. 3) . These analyses indicate that the propositus is homozygous for the Tyr-316 --ter mutation as a result of inheriting the corresponding DNA sequence alteration from each heterozygous parent (Fig. 3) . Each ofhis living siblings is not erythroid H deficient and is either heterozygous for this allele or is homozygous for the wildtype allele (Fig. 3) . This is a rare allele in the general population, since this DNA sequence alteration was not detected in an analysis of >100 alleles from unrelated H-positive individuals (data not shown). These data indicate that the Tyr-316 --ter mutation is responsible for the H-deficient phenotype of the propositus. When considered together with enzyme kinetic data and chromosomal localization results, the data also strongly support the hypothesis that this gene corresponds to the human H blood group locus (9).
Nonsense and Missense Mutations Inactivate the a(1,2)FT Gene in para-Bombay Individuals. As a direct test of the hypothesis that the H and SE loci are distinct a(1,2)FT genes, and to further support the assignment of this gene to the H locus, we examined both alleles of this gene in a Secretorpositive, erythroid H-deficient individual [para-Bombay phenotype (1, 2, 8) ; individual Y in Fig. 1 ]. We found that the coding region of each allele in this para-Bombay person contains a single base sequence alteration relative to corresponding positions in the wild-type sequence (Fig. 1) (indicated by *) destroys aBstNI restriction site and creates anAlu I site (see Fig. lb) . PCR was used to amplify 409 bp of the a(1,2)FT gene encompassing this position (top), using primers (indicated by arrows) described in Materials and Methods. BstNI cleavage of this segment (middle, labeled B) from the wild-type allele yields 123-and 24-bp fragments, whereas a single diagnostic BstNI-resistant 147-bp fragment is obtained with the X4 Bombay allele (shaded). Conversely, Alu I digestion (bottom, labeled A) of the PCR fragment generated from the X4 Bombay allele yields 292-and 117-bp fragments (shaded), whereas the 409-bp segment from the wild-type allele is not cleaved by Alu I. (b) Analysis of allele-specific restriction site polymorphisms. Genomic DNA was subjected to PCR amplification and restriction endonuclease cleavage as outlined in a. Cloned DNA segments containing wild-type sequence (Hc) orthe X4 mutation (Bc) served as control templates. PCR fragments were digested with either BstNI ( allele contains a missense mutation at codon 164 that predicts the substitution ofa histidine residue for the wild-type leucine residue at this position (Y1; Leu-164 --His). The other allele contains a termination codon at a position corresponding to amino acid residue 276 (Y2; Gln-276 -* ter) and predicts a protein 90 amino acids shorter than the wild-type enzyme. Both mutant alleles yield undetectable a(1,2)FT activity when tested by transfection (Fig. 2) .
Inheritance of these alleles was examined in this paraBombay pedigree, using restriction site cleavage polymorphisms for BstNI, Bfa I, and Alu I (see Fig. 1 ) and by allele-specific oligonucleotide hybridization analysis of the Y1 allele. These analyses demonstrate that the para-Bombay sibling of the propositus is also a compound heterozygote for the Y1 and Y2 alleles (Fig. 4) . All other family members examined are not erythroid H deficient and are either heterozygous for one of the two mutant alleles (parents and children of the para-Bombay individuals) or maintain the wild-type sequence at both positions (other siblings). Taken together with the results from the Bombay alleles, these data indicate that inactivating point mutations within the coding sequence of this a(1,2)FT gene are responsible for H blood Fig. 3 . PCR fragments shown in a and b were generated by using genomic DNA from family members or by using cloned DNA segments containming wild-type sequence (Hc) Fig. la ) and subjected to Southern blot analysis (11) using the coding region of the a(1,2)FT cDNA as a probe (9) . Hybridization was done at 42TC, with a final wash at 65TC in 2x standard saline citrate/0.2% SDS. Molecular size standards (kb) are indicated on the right. (9, 12) and chromosomal localization (9) (19) ]. Given the high frequency of non-Secretor individuals (=20% of Caucasians; ref. 1), the a(1,2)FT encoded by the SE locus is apparently also not essential (at least in the adult human), although a definition of the molecular basis for null alleles at this locus must await the isolation and characterization of this gene.
These observations suggest that any evolutionary constraints that may have once selected for functional alleles at these a(1,2)FT loci have since ceased to be operative in adult humans. It remains possible, however, that related loci maintain compensating functional redundancy sufficient to sustain a normal phenotype. Indeed, by analogy to the family of human a-(1,3)-fucosyltransferase genes (17) , it remains possible that other a(1,2)FTs (20) , encoded by as yet uncloned genes, may fulfill one or more essential roles. Moreover, such roles (like embryo implantation in the mouse; ref. 21 ) may be operative in tissues, or at developmental stages, not yet examined in Homo sapiens. Alternatively, the functions maintained by terminal a(1,2)fucose linkages may be accomplished by other terminal sugar moieties that are, in turn, encoded by nonpolymorphic glycosyltransferases (discussed in ref. 22 ). These issues are not idiosyncratic to the a(1,2)FTs. Null alleles are rather common within other glycosyltransferase genes (the ABO, Lewis, P, and Sda blood group systems, for example; see ref. 1) and in some instances have been shown to correspond to inactivating coding sequence mutations (23) . Experimental tests of hypotheses concerning a function(s) of these and other mammalian glycosyltransferases, and their cognate oligosaccharide products, should be facilitated with the use of cloned glycosyltransferase genes in conjunction with transgenic and gene disruption technologies (24) .
